Filana Therapeutics, Inc.
FLNA· Nasdaq
FLNAFilana Therapeutics, Inc.
Filed Feb 8, 2013 · 10-K · 39 days after period end · 0001193125-13-046147
| Metric | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|
| Revenue | $2.47M | $2.75M | — |
| Net Income | -$1.80M | -$391.00K | — |
| EPS Diluted | -$0.04 | -$0.01 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Filana Therapeutics, Inc. · CIK 1069530 · Engraved from SEC EDGAR
ended Dec 31, 2012 · filed Feb 8, 2013 · 39 d after period end
